Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach (Q34982523)

5 August 2017

0 references

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach (English)

1 reference

5 August 2017

1 reference

1 reference

Charles B. L. M. Majoie

1 reference

5 August 2017

Liesbeth Reneman

1 reference

5 August 2017

Jan Booij

1 reference

5 August 2017

Gerard J. Den Heeten

1 reference

5 August 2017

Wim Van Den Brink

1 reference

5 August 2017

publication date

1 December 2001

1 reference

5 August 2017

published in

Human Psychopharmacology

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

579-588

1 reference

Functional cerebral imaging by susceptibility-contrast NMR.

5 August 2017

cites work

1 reference

[125I]RTI-55: a potent ligand for dopamine transporters

21 January 2018

1 reference

Memory impairment in abstinent MDMA ("Ecstasy") users

21 January 2018

1 reference

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

21 January 2018

1 reference

Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects

21 January 2018

1 reference

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

21 January 2018

1 reference

Serotonin in the regulation of brain microcirculation

21 January 2018

1 reference

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain

21 January 2018

1 reference

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

21 January 2018

1 reference

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

Apparent diffusion coefficient on rat brain and nerves intoxicated with methylmercury

21 January 2018

1 reference

Imaging of serotonin and dopamine transporters in the living human brain

21 January 2018

1 reference

SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates

21 January 2018

1 reference

Diffusion MR imaging: clinical applications

21 January 2018

1 reference

Caveat emptor: editors beware

21 January 2018

1 reference

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

5-HT system and cognition

21 January 2018

1 reference

Neurotoxicity of MDMA and related compounds: anatomic studies

21 January 2018

1 reference

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

Diffusion tensor MR imaging of the human brain

21 January 2018

1 reference

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

21 January 2018

1 reference

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

21 January 2018

1 reference

Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging

21 January 2018

1 reference

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

21 January 2018

1 reference

Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?

21 January 2018

1 reference

123/125IRTI-55, an in vivo label for the serotonin transporter

21 January 2018

1 reference

Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors

21 January 2018

1 reference

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients

21 January 2018

1 reference

"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study

21 January 2018

1 reference

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

21 January 2018

1 reference

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging

21 January 2018

1 reference

Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence

21 January 2018

1 reference

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

21 January 2018

1 reference

21 January 2018

1 reference

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

21 January 2018

1 reference

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

21 January 2018

1 reference

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

21 January 2018

1 reference

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

21 January 2018

1 reference

Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord

21 January 2018

1 reference

Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4- methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide as a potential 5HT2 receptor tracer for SPE(C)T

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HUP.347

1 reference

5 August 2017

1 reference